Optomed Oyj (OPTOMED.HE)
EUR 4.3
(-1.71%)
EUR 4.3
(-1.71%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.27 EUR | 27.03% |
| 2022 | -0.37 EUR | -15.63% |
| 2021 | -0.32 EUR | -33.33% |
| 2020 | -0.24 EUR | 25.0% |
| 2019 | -0.32 EUR | -232.99% |
| 2018 | -0.10 EUR | 56.32% |
| 2017 | -0.22 EUR | -4.76% |
| 2016 | -0.21 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.06 EUR | 30.46% |
| 2024 Q2 | -0.10 EUR | -56.99% |
| 2023 Q2 | -0.08 EUR | -10.57% |
| 2023 FY | - EUR | 27.03% |
| 2023 Q4 | -0.09 EUR | -236.76% |
| 2023 Q3 | -0.03 EUR | 67.5% |
| 2023 Q1 | -0.08 EUR | 20.65% |
| 2022 Q3 | -0.10 EUR | -0.94% |
| 2022 Q4 | -0.10 EUR | 1.75% |
| 2022 Q2 | -0.10 EUR | 3.8% |
| 2022 Q1 | -0.10 EUR | 28.57% |
| 2022 FY | - EUR | -15.63% |
| 2021 FY | - EUR | -33.33% |
| 2021 Q1 | -0.05 EUR | 6.1% |
| 2021 Q2 | -0.06 EUR | -40.04% |
| 2021 Q4 | -0.14 EUR | -125.08% |
| 2021 Q3 | -0.06 EUR | 3.86% |
| 2020 Q4 | -0.05 EUR | -56.19% |
| 2020 Q2 | -0.08 EUR | 30.5% |
| 2020 Q3 | -0.03 EUR | 62.23% |
| 2020 FY | - EUR | 25.0% |
| 2020 Q1 | -0.12 EUR | -1746.15% |
| 2019 Q3 | -0.10 EUR | -27.27% |
| 2019 FY | - EUR | -232.99% |
| 2019 Q4 | -0.01 EUR | 93.17% |
| 2019 Q1 | -0.04 EUR | -172.67% |
| 2019 Q2 | -0.07 EUR | -71.56% |
| 2018 Q3 | -0.04 EUR | 0.0% |
| 2018 Q4 | 0.06 EUR | 266.2% |
| 2018 FY | - EUR | 56.32% |
| 2017 FY | - EUR | -4.76% |
| 2016 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|